Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Anticancer Research Year : 2012

Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.

Abstract

Anthracycline extravasation is an uncommon but very serious complication. Very few data are available in the literature concerning the consequences and the management of extravasation of liposomal doxorubicin. This report describes the cases of two patients with liposomal doxorubicin extravasation who developed irritant reaction without vesicant or necrotic lesions. It is concordant with other cases described in the literature and suggests that extravasation of liposomal doxorubicin can be relatively well tolerated. The process applied to extravasations of irritant and non-vesicant agents could be used to manage extravasations of liposomal doxorubicin.

Domains

Immunology
No file

Dates and versions

inserm-00821491 , version 1 (10-05-2013)

Identifiers

  • HAL Id : inserm-00821491 , version 1
  • PUBMED : 22493389

Cite

Elsa Curtit, Loïc Chaigneau, Julien Pauchot, Thierry Nguyen, Virginie Nerich, et al.. Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.. Anticancer Research, 2012, 32 (4), pp.1481-3. ⟨inserm-00821491⟩

Collections

INSERM UNIV-FCOMTE
99 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More